Emerging Infectious Diseases (Dec 2017)

Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network

  • Eric S. Halsey,
  • Meera Venkatesan,
  • Mateusz M. Plucinski,
  • Eldin Talundzic,
  • Naomi W. Lucchi,
  • Zhiyong Zhou,
  • Celine I. Mandara,
  • Hawela Moonga,
  • Busiku Hamainza,
  • Abdoul Habib Beavogui,
  • Simon Kariuki,
  • Aaron M. Samuels,
  • Laura C. Steinhardt,
  • Don P. Mathanga,
  • Julie Gutman,
  • Yves Eric Denon,
  • Aline Uwimana,
  • Ashenafi Assefa,
  • Jimee Hwang,
  • Ya Ping Shi,
  • Pedro Rafael Dimbu,
  • Ousmane Koita,
  • Deus S. Ishengoma,
  • Daouda Ndiaye,
  • Venkatachalam Udhayakumar

DOI
https://doi.org/10.3201/eid2313.170366
Journal volume & issue
Vol. 23, no. 13

Abstract

Read online

Antimalarial drug resistance is an evolving global health security threat to malaria control. Early detection of Plasmodium falciparum resistance through therapeutic efficacy studies and associated genetic analyses may facilitate timely implementation of intervention strategies. The US President’s Malaria Initiative–supported Antimalarial Resistance Monitoring in Africa Network has assisted numerous laboratories in partner countries in acquiring the knowledge and capability to independently monitor for molecular markers of antimalarial drug resistance.

Keywords